Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Okada

Showing results (221-230 of 254) with videos related to

Pageof 26
Sort By:
Acta Haematologica|May 23, 2022
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell TransplantationShunto Kawamura, Masaharu Tamaki, Yuhei Nakamura, et al.
Transplantation and Cellular Therapy|June 24, 2022
Low-Intensity Immunosuppressive Therapy for Chronic Graft-versus-Host DiseaseKazuki Yoshimura, Shun-Ichi Kimura, Hideki Nakasone, et al.
British Journal of Haematology|June 15, 2023
Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patientsMachiko Kusuda, Hideki Nakasone, Kazuki Yoshimura, et al.
Journal of Gastroenterology|June 3, 2022
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantationYosuke Okada, Hideki Nakasone, Yuhei Nakamura, et al.
Cytotherapy|June 21, 2023
Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patientsMasaharu Tamaki, Yu Akahoshi, Yosuke Okada, et al.
Transplantation and Cellular Therapy|September 5, 2025
Risk Stratification Using DIPSS and Splenomegaly in Myelofibrosis Treated with Pre-Transplant JAK inhibitorsYosuke Okada, Kazuki Sakatoku, Shuichi Shirane, et al.
Journal of Bone and Mineral Metabolism|March 28, 2024
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosisYoshiya Tanaka, Satoshi Soen, Shintaro Hirata, et al.
International Journal of Hematology|July 22, 2023
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantationShimpei Matsumi, Shun-Ichi Kimura, Yuhei Nakamura, et al.
BMJ Open Diabetes Research & Care|January 14, 2021
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)Kohjiro Ueki, Yukio Tanizawa, Jiro Nakamura, et al.
Hematological Oncology|August 14, 2022
Prognostic impact of complex karyotype on post-transplant outcomes of myelofibrosisYosuke Okada, Katsuto Takenaka, Makoto Murata, et al.
Pageof 26

Showing results (221-230 of 254) with videos related to

Sort By:
Pageof 26
Acta Haematologica|May 23, 2022
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell TransplantationShunto Kawamura, Masaharu Tamaki, Yuhei Nakamura, et al.
Transplantation and Cellular Therapy|June 24, 2022
Low-Intensity Immunosuppressive Therapy for Chronic Graft-versus-Host DiseaseKazuki Yoshimura, Shun-Ichi Kimura, Hideki Nakasone, et al.
British Journal of Haematology|June 15, 2023
Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patientsMachiko Kusuda, Hideki Nakasone, Kazuki Yoshimura, et al.
Journal of Gastroenterology|June 3, 2022
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantationYosuke Okada, Hideki Nakasone, Yuhei Nakamura, et al.
Cytotherapy|June 21, 2023
Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patientsMasaharu Tamaki, Yu Akahoshi, Yosuke Okada, et al.
Transplantation and Cellular Therapy|September 5, 2025
Risk Stratification Using DIPSS and Splenomegaly in Myelofibrosis Treated with Pre-Transplant JAK inhibitorsYosuke Okada, Kazuki Sakatoku, Shuichi Shirane, et al.
Journal of Bone and Mineral Metabolism|March 28, 2024
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosisYoshiya Tanaka, Satoshi Soen, Shintaro Hirata, et al.
International Journal of Hematology|July 22, 2023
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantationShimpei Matsumi, Shun-Ichi Kimura, Yuhei Nakamura, et al.
BMJ Open Diabetes Research & Care|January 14, 2021
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)Kohjiro Ueki, Yukio Tanizawa, Jiro Nakamura, et al.
Hematological Oncology|August 14, 2022
Prognostic impact of complex karyotype on post-transplant outcomes of myelofibrosisYosuke Okada, Katsuto Takenaka, Makoto Murata, et al.
Pageof 26